These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11845389)

  • 1. [Immunity against prions?].
    Heppner FL; Aguzzi A
    Dtsch Med Wochenschr; 2002 Feb; 127(7):328-30. PubMed ID: 11845389
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity against prions?
    Heppner FL; Arrighi I; Kalinke U; Aguzzi A
    Trends Mol Med; 2001 Nov; 7(11):477-9. PubMed ID: 11689311
    [No Abstract]   [Full Text] [Related]  

  • 3. PrP expression in B lymphocytes is not required for prion neuroinvasion.
    Klein MA; Frigg R; Raeber AJ; Flechsig E; Hegyi I; Zinkernagel RM; Weissmann C; Aguzzi A
    Nat Med; 1998 Dec; 4(12):1429-33. PubMed ID: 9846583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infectious proteins or prions. A new mechanism of disease].
    Benítez-Bribiesca L
    Gac Med Mex; 1998; 134(1):107-9. PubMed ID: 9658704
    [No Abstract]   [Full Text] [Related]  

  • 5. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
    Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A crucial role for B cells in neuroinvasive scrapie.
    Klein MA; Frigg R; Flechsig E; Raeber AJ; Kalinke U; Bluethmann H; Bootz F; Suter M; Zinkernagel RM; Aguzzi A
    Nature; 1997 Dec 18-25; 390(6661):687-90. PubMed ID: 9414161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunological approach to prion diseases.
    Paraf A
    Med Hypotheses; 1998 Jan; 50(1):85-90. PubMed ID: 9488187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What are the prions?].
    Piédrola Angulo G
    An R Acad Nac Med (Madr); 2001; 118(3):599-604. PubMed ID: 11783039
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-prion antibodies for prophylaxis following prion exposure in mice.
    Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
    Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
    Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.
    Piccardo P; Langeveld JP; Hill AF; Dlouhy SR; Young K; Giaccone G; Rossi G; Bugiani M; Bugiani O; Meloen RH; Collinge J; Tagliavini F; Ghetti B
    Am J Pathol; 1998 Jun; 152(6):1415-20. PubMed ID: 9626045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could immunomodulation be used to prevent prion diseases?
    Wisniewski T; Goñi F
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):307-17. PubMed ID: 22397565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostics for TSE agents.
    Raeber AJ; Oesch B
    Dev Biol (Basel); 2006; 123():313-23; discussion 349-54. PubMed ID: 16566455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocytes and neuroinvasion.
    Brown P
    Nature; 1997 Dec 18-25; 390(6661):662-3. PubMed ID: 9414158
    [No Abstract]   [Full Text] [Related]  

  • 15. A brief overview of bovine spongiform encephalopathy and related diseases including a TSE risk analysis of bovine starting materials used during the manufacture of vaccines for use in humans.
    Bradley R
    Przegl Epidemiol; 2001; 55(3):387-405. PubMed ID: 11761847
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.
    Heppner FL; Musahl C; Arrighi I; Klein MA; Rülicke T; Oesch B; Zinkernagel RM; Kalinke U; Aguzzi A
    Science; 2001 Oct; 294(5540):178-82. PubMed ID: 11546838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
    Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
    J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spongiform diseases. After the crisis: more questions about prions.
    Enserink M
    Science; 2005 Dec; 310(5755):1756-8. PubMed ID: 16357237
    [No Abstract]   [Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease and transplantation: facts and fables.
    Dormont D
    Transplant Proc; 1996 Oct; 28(5):2931-3. PubMed ID: 8908129
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent developments in mucosal vaccines against prion diseases.
    Sakaguchi S; Arakawa T
    Expert Rev Vaccines; 2007 Feb; 6(1):75-85. PubMed ID: 17280480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.